Gene · 3535
Papers1,872
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,872
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AATF/Che-1 localizes to paraspeckles and suppresses R-loops accumulation and interferon activation in Multiple Myeloma. | EMBO J | 2022 | 35929179 | PubTator, text mining | PubMed |
| Immune repertoire analysis of normal Chinese donors at different ages. | Cell Prolif | 2022 | 35929064 | PubTator, text mining | PubMed |
| Molecular map of chronic lymphocytic leukemia and its impact on outcome. | Nat Genet | 2022 | 35927489 | PubTator, text mining | PubMed |
| The Therapeutic Potential of Targeting NIK in B Cell Malignancies. | Front Immunol | 2022 | 35911754 | PubTator, text mining | PubMed |
| Human antibodies to SARS-CoV-2 with a recurring YYDRxG motif retain binding and neutralization to variants of concern including Omicron. | Commun Biol | 2022 | 35906394 | PubTator, text mining | PubMed |
| Tumor Resident, B-Cell Receptor Chemical Characteristics Associated with Better Overall Survival for Neuroblastoma. | J Mol Neurosci | 2022 | 35896862 | PubTator, text mining | PubMed |
| Safety and Immunogenicity of Combined DNA-Polyethylenimine and Oral Bacterial Idiotypic Vaccine for Patients with B-Cell Non-Hodgkin Lymphoma: A Pilot Study. | Cancers (Basel) | 2022 | 35884359 | PubTator, text mining | PubMed |
| Dysregulation of Innate and Adaptive Immune Responses in Asymptomatic SARS-CoV-2 Infection with Delayed Viral Clearance. | Int J Biol Sci | 2022 | 35874943 | PubTator, text mining | PubMed |
| Human T-bet governs the generation of a distinct subset of CD11chighCD21low B cells. | Sci Immunol | 2022 | 35867801 | PubTator, text mining | PubMed |
| Benchmarking computational methods for B-cell receptor reconstruction from single-cell RNA-seq data. | NAR Genom Bioinform | 2022 | 35855325 | PubTator, text mining | PubMed |
| CD33-targeting extracellular vesicles deliver antisense oligonucleotides against FLT3-ITD and miR-125b for specific treatment of acute myeloid leukaemia. | Cell Prolif | 2022 | 35851970 | PubTator, text mining | PubMed |
| Redefining the high-grade B cell lymphoma with double/triple rearrangements of MYC and BCL2/BCL6 genes. Learning from a case report. | EJHaem | 2022 | 35846201 | PubTator, text mining | PubMed |
| Pathogenic autoantibodies to IFN-γ act through the impedance of receptor assembly and Fc-mediated response. | J Exp Med | 2022 | 35833912 | PubTator, text mining | PubMed |
| DeepLoop robustly maps chromatin interactions from sparse allele-resolved or single-cell Hi-C data at kilobase resolution. | Nat Genet | 2022 | 35817982 | PubTator, text mining | PubMed |
| Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV. | Blood Adv | 2022 | 35816682 | PubTator, text mining | PubMed |
| Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations. | Front Oncol | 2022 | 35814434 | PubTator, text mining | PubMed |
| Characterization of the Intra-tumoral B Cell Immunoglobulin Repertoire Is of Prognostic Value for Esophageal Squamous Cell Carcinoma. | Front Immunol | 2022 | 35812448 | PubTator, text mining | PubMed |
| Novel Approaches in Molecular Characterization of Classical Hodgkin Lymphoma. | Cancers (Basel) | 2022 | 35805000 | PubTator, text mining | PubMed |
| Immunoglobulin Gene Sequence as an Inherited and Acquired Risk Factor for Chronic Lymphocytic Leukemia. | Cancers (Basel) | 2022 | 35804817 | PubTator, text mining | PubMed |
| Landscape of B Cell Receptor Repertoires in COVID-19 Patients Revealed Through CDR3 Sequencing of Immunoglobulin Heavy and Light Chains. | Immunol Invest | 2022 | 35797435 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3535/papers?page=18